# 2026-19706: NIH Wants to Tell Clinical Trial Guinea Pigs the Results

2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants, is a Federal Register notice from Health and Human Services Department, National Institutes of Health published 2026-09-25, effective To ensure consideration, comments must be submitted on or before October 26, 2026.; PRIA reads it as touching household money (as of 2026-10-02).

- Canonical: https://policyrisk.com/federal-register/2026-19706
- As of: 2026-10-02
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-19706
- Title: Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
- Type: Notice
- Agencies: Health and Human Services Department; National Institutes of Health
- Citation: 91 FR 60972
- Published: 2026-09-25
- Effective: To ensure consideration, comments must be submitted on or before October 26, 2026.
- Comments close: 2026-10-26
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-10-02

## In one line

NIH Wants to Tell Clinical Trial Guinea Pigs the Results

## Summary

The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!

## Abstract

NIH seeks public input on its proposed NIH Policy on Sharing Summary Level Study Results with Clinical Research Participants, including ways to promote and enable the research community to share summary level study results with clinical research participants.

## Effects PRIA read

- Mandatory plain‑language results for participants: benefit, medium. If a study is supported in whole or in part by NIH, researchers and institutions must responsibly share summary level study results in plain language with clinical research participants, unless sharing is justifiably not appropriate and an exception is approved. This requirement applies to all NIH‑…
- Deadlines for sharing study summaries: benefit, medium. For NIH‑supported clinical trials, summary level study results must be shared no later than one year after the study's primary completion date or by the date results must be reported in ClinicalTrials.gov under NIH policy, whichever is later. For extramural clinical research that is not a clinical…
- Funding consequences for noncompliance: cost, medium. All recipients of NIH support for clinical research must comply with the Policy; failure to comply may lead to enforcement actions such as additional special terms and conditions, termination, or other actions that may affect future NIH funding decisions for the recipient institution, consistent wi…
- Participants must be offered results option: benefit, low. Researchers must ensure that research participants are offered summary level study results, whether or not participants ultimately receive those results. If sharing will not occur, researchers should request an exception (generally before enrollment) and if sharing becomes impossible must inform pa…
- NIH may provide supplemental guidance and support: benefit, low. NIH is considering issuing supplemental guidance and resources to help researchers share summary level study results in plain language, and is seeking input on the types of activities and anticipated costs needed to implement this requirement for different kinds of studies.

## Related documents

- [2026-22871](https://policyrisk.com/federal-register/2026-22871): Center for Scientific Review; Notice of Closed Meetings, 2026-11-10
- [2026-22550](https://policyrisk.com/federal-register/2026-22550): Center for Scientific Review; Notice of Closed Meetings, 2026-11-05
- [2026-22558](https://policyrisk.com/federal-register/2026-22558): Center for Scientific Review; Notice of Closed Meetings, 2026-11-05
- [2026-22339](https://policyrisk.com/federal-register/2026-22339): Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human, 2026-11-02
- [2026-22196](https://policyrisk.com/federal-register/2026-22196): National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 2026-10-30
- [2026-22111](https://policyrisk.com/federal-register/2026-22111): Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 2026-10-29

## Sources
- [2026-19706 on federalregister.gov](https://www.federalregister.gov/documents/2026/09/25/2026-19706/draft-nih-policy-on-sharing-summary-level-study-results-with-clinical-research-participants)
- [2026-19706 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-09-25/pdf/2026-19706.pdf)

## Related
- [Previous: 2026-19704, Robotically-Assisted Surgical Devices-Premarket Submissions; Draft Guidance for…](https://policyrisk.com/federal-register/2026-19704)
- [Next: 2026-19707, Medicaid and Children's Health Insurance Program (CHIP) Generic Information Col…](https://policyrisk.com/federal-register/2026-19707)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-19706 (as of 2026-10-02).